Anoplin

General Information


DRACP ID  DRACP02186

Peptide Name   Anoplin

Sequence  GLLKRIKTLL

Sequence Length  10

UniProt ID  P0C005 

PubChem CID  10307332 

Origin  Anoplius samariensis

Type  Native peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50>256 µM MTT assay 1 h 1

Hemolytic Activity  Mouse erythrocytes: 10% Hemolysis>256 µM

Normal (non-cancerous) Cytotoxicity  HEK293T: IC50>256 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  2MJQ  

Predicted Structure  DRACP02186

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C54H103N15O12

Absent amino acids  ACDEFHMNPQSVWY

Common amino acids  L

Mass  131523

Pl  11.82

Basic residues  3

Acidic residues  0

Hydrophobic residues  5

Net charge  3

Boman Index  -305

Hydrophobicity  63

Aliphatic Index  195

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31676352

Title  Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria

Doi 10.1016/j.ejps.2019.105123

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_3116

DRACP is developed by Dr.Zheng's team.